Prohibits the possession and sale of certain mitragynine-derived products

HB 3173 prohibits the possession, sale, distribution, and advertising of products containing specific compounds derived from kratom, including those with over 2% of 7-hydroxymitragynine (7-OH) or mitragynine pseudoindoxyl. It directly affects businesses selling such products and consumers who purchase them. The law includes an exception allowing research institutions to handle these products for scientific or medical research. This bill aims to restrict access to certain kratom-based products while permitting legitimate research activities.